Hyaluronic AcidvsResveratrol

Hyaluronic acid is a glycosaminoglycan (GAG) composed of repeating D-glucuronic acid and N-acetyl-D-glucosamine disaccharides. Its hydroxyl and carboxyl groups create strong hydrogen bonding with water—each molecule binds up to 1000x its weight in water. High molecular weight HA (>1000 kDa) forms a viscoelastic film on the stratum corneum, reducing transepidermal water loss (TEWL). Medium weight (100-1000 kDa) penetrates the upper epidermis. Low molecular weight HA (<100 kDa) reaches the dermis and binds CD44 and RHAMM receptors on fibroblasts, triggering ERK and PI3K signaling that stimulates fibroblast proliferation, hyaluronan synthase (HAS2) expression, and collagen I/III synthesis. Sodium hyaluronate—the salt form—has improved stability and penetration. Multi-weight formulations provide surface hydration and deeper dermal stimulation.

Resveratrol activates SIRT1 (sirtuin 1), a NAD+-dependent deacetylase that deacetylates histones and non-histone targets including p53, FOXO transcription factors, and NF-κB, regulating cellular stress response, DNA repair, autophagy, and inflammatory pathways in keratinocytes and fibroblasts. It scavenges superoxide anion, hydroxyl radical, and metal-induced free radicals through its phenolic hydroxyl groups. Resveratrol inhibits NF-κB nuclear translocation and downstream cytokine production (TNF-α, IL-1β, IL-6), reducing UV-induced inflammation. It inhibits tyrosinase (mild brightening), matrix metalloproteinase-9 (MMP-9, gelatinase B) to prevent collagen and elastin breakdown, and AP-1 (c-Fos/c-Jun) to reduce photoaging-related gene expression. It may also activate Nrf2, upregulating antioxidant enzymes (HO-1, NQO1). Topical application achieves higher skin tissue concentrations than oral supplementation due to first-pass metabolism. Stability is improved in anhydrous or encapsulated formulations.